Gene Transfer Therapy for Childhood Diseases: Everything You Need to Know
Gene therapies can replace the single nonworking gene, so that it can now provide its necessary function
If you’ve spent any time reading up on or living life with a rare condition, chances are you’ve come across the terms “genetic disorder,” and “gene therapy.” But what exactly do they mean? And what differentiates them from other diseases and treatments?
A genetic disease is caused by nonworking or missing genes. Scientists recently found that genes may play a part in many diseases. Genetic diseases can be the result of a mutation in one gene or multiple genes. Some mutations are inherited from one or both parents. Other diseases are caused by mutations that occur randomly, or due to environmental exposure (such as cigarette smoke—which causes cancer).
Genetic diseases that are the result of a single, nonworking, or missing gene make an easier target for gene therapies. These therapies can replace the single nonworking gene so that it can now provide its necessary function.
Some of the one-gene group of rare genetic disorders being studied for gene therapies are:
Cystic fibrosis — caused by a mutation in the CFTR gene, which makes the body unable to produce a specific protein essential for free-flowing mucous. A thick sticky mucous builds up in the lining of the lungs.
Duchennes Muscular Dystrophy — the result of a mutation of the DMD gene, necessary for producing a protein responsible for muscle development.
Gauchers Disease — caused by one gene, GBA1, but can have many different mutations, and therefore there are many different types of the disease. There are two categories of Gaucher disease: those that affect the nervous system (Types 2 & 3) and those that do not (Type 1).
Hemophilia — there is a type A and type B, which are both caused by a mutation in either the F8 or the F9 genes. Because of this absent gene, a person with hemophilia is missing an important element needed for their blood to clot after an injury.
Sanfilippo Syndrome (MPS IIIa) — caused by a non-functional or missing SGSH gene which produces an enzyme that’s essential for processing sugar molecules. This causes a buildup in many areas of the body, especially the brain, leading to neurological and developmental issues.
Spinal Muscle Atrophy (SMA) — caused by a missing or non-functional SMN1 gene responsible for a protein needed by the nerves that are connected to muscle function (motor neurons). Over time, these motor neurons die, and the muscles required for walking, talking, eating, and breathing eventually don’t work.
Clinical studies for gene therapies are in development for many orphan diseases. Some of these studies are specifically looking for young children, and are being conducted in centers that specialize in the study of genetic diseases in children.
There are gene therapy studies for rare blood diseases like Sickle Cell Disease, Hemophilia, and Wiskott-Aldrich Syndrome, and for neurological disorders like Sanfilippo Syndrome, and muscular disorders like SMA. Although gene therapies do not cure the disease, they do address the root cause of the disorder. They are also given as a one-time treatment, which can “fix” the problem caused by the missing gene. However, since most of gene therapies are relatively new, how long the effect, or the “fix,” will last is still unknown. Centers and researchers who are involved in clinical studies of gene therapies are highly knowledgeable about genetic diseases and gene therapies and are likely to have the most experience in using them.
If you are interested in seeing if there are any studies available related to your condition, you can search clinicaltrials.gov for the name of the condition and, under any other search terms: gene therapy. In the future, KnowRare will provide additional guidance on how to find out more about gene therapies.
Source: NIH National Human Genome Research Institute
https://www.genome.gov/Clinical-Research/Current-NHGRI-Clinical-Studies
Latest from Know Rare
Discover the latest treatments for IgA Nephropathy (IgAN), a rare kidney disease. Learn how current medications and emerging therapies work to slow progression, reduce proteinuria, and protect kidney function.
Discover how patient education empowers individuals with rare diseases to better understand their diagnosis, make informed decisions, and actively participate in their treatment plans. Learn why clear, compassionate communication is key to improving outcomes in rare disease care.
A heartfelt mother’s account on five years of navigating pediatric specialist waiting rooms with her medically complex child.
A powerful personal journey through Koolen-de Vries syndrome, ADHD, and neurodivergent parenting. Discover how one mother turned diagnosis into empowerment, embracing difference, healing guilt, and raising resilient, remarkable children in a world that doesn’t always understand.
Toni Roberts lives with Epidermolysis Bullosa, a rare genetic disorder that causes the skin to be extremely fragile and prone to blistering and tearing. Toni’s condition profoundly impacted her older sister, Cady Ward. Witnessing Toni’s daily struggles and challenges, Cady was inspired to become an advocate for rare disease and take on an extraordinary challenge—run an ultra-marathon.
Dr. David Fajgenbaum was in his third year of medical school when a rare and mysterious illness derailed his plans. Crushing fatigue, abdominal pain, and multiple swollen lymph nodes progressed rapidly, and he found himself in the ICU with multiple system organ failure. Recovering from the brink of death, he was diagnosed with Castleman disease (CD), a rare condition that at the time was thought to be a lymph node disease with similarities to cancer.
Learn about Dr. Rohit Aggarwal’s efforts in creating more centers of excellence for myositis, as well as educating, empowering, and connecting patients to clinical trials.
Recognizing the need for an effective way to treat becker muscular dystrophy, researchers have been studying the cause of muscle loss, and ways to stop it from happening.
After his diagnosis of limb-girdle muscular dystrophy type 2B at age 21, Chris initially opted for a safe career path, choosing jobs with steady income, benefits, and predictability. However, this decision made him feel like something was missing. Find out how Chris was finally able to follow his heart, finding purpose and contentment in becoming a writer.
Learn more about CureGRIN, founded in 2018 by parents of children diagnosed with GRIN Disorder to help find cures and therapies for people around the world suffering from these conditions.
Learn about the incredible story of Edward Gent, a Sports Nutritionist diagnosed with MMN, who decided to create an app to help others worldwide with their disease and symptom management.
Find out about 7 research areas identified as priorities in Sickle Cell Research and about a sickle cell disease drug, which was originally approved for treatment, that has been taken off the market.
It’s no secret that it is difficult to get to a pain medicine specialist. There are just so many people in pain who cannot find relief, and are looking for help. Learn about Bliss Health, which provides access to pain management services through virtual consultations, through a dedicated team of medical professionals who specialize in the diagnosis, treatment, and ongoing management of various types of chronic and acute pain conditions.
There are over 50 million people in the United States that live with chronic pain. However, researchers studying pain have learned something important: perception of pain is personal, and may have more to do with other factors than just the physical cause of the pain.
If you are coming across high copays and struggling to afford your treatment plan, here are a few options that may help you reduce the costs of your medications.
At age 15, Becca Salky became her own medical detective, playing a key role in uncovering her diagnosis. Now, as a Clinical Research Coordinator at Massachusetts General Hospital, she focuses on spreading awareness about MOG, finding better diagnostic tools, leading clinical trials, and fighting gender disparity.
On the “Rare Insights” podcast we bridge the gap between those living with rare diseases and the biopharmaceutical industry.
Why Men’s Health Week (June 10-16) matters for the Rare Community, and how you can take part.
June is Pride Month, and at Know Rare, we are committed to celebrating the rich diversity within the rare disease community.
Journalist Lindsay Guentzel describes navigating a diagnostic odyssey and how she manages day-to-day life with myositis in an impactful webinar.
When you live with a rare disease, the joyful experiences risks can bring are all the more valuable.
This summer, NMOSD and MOGAD patients, caregivers, clinicians, nurses, researchers, and advocates are invited to join The Sumaira Foundation at Emory for TSF's Atlanta Patient Day.
Know Rare writer Gina DeMillo Wagner’s new memoir, Forces of Nature explores powerful themes related to caregiving and rare disease.
Journalist Lindsay Guentzel offers an inside look at life with the rare muscular condition.
This May, Know Rare is shining a light on myositis, a group of rare autoimmune muscle diseases that can have profound effects on daily life. This is an important time for the myositis community and the rare disease community at large: a time to share stories from those living with the condition, share more information about the current state and future of the disease, and advocate for better treatments that will ultimately enhance the quality of life for those impacted by it. Whether you're a patient, caregiver, or advocate, join us in raising awareness and supporting those affected by myositis.
Author Chris Anselmo explains why being mindful of your pace can have major benefits for your health and well-being, and offers some tips to help.
